Uri Kopylov

20.3k total citations · 1 hit paper
277 papers, 8.6k citations indexed

About

Uri Kopylov is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Uri Kopylov has authored 277 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 197 papers in Genetics, 133 papers in Epidemiology and 107 papers in Surgery. Recurrent topics in Uri Kopylov's work include Inflammatory Bowel Disease (196 papers), Microscopic Colitis (103 papers) and Gastrointestinal Bleeding Diagnosis and Treatment (57 papers). Uri Kopylov is often cited by papers focused on Inflammatory Bowel Disease (196 papers), Microscopic Colitis (103 papers) and Gastrointestinal Bleeding Diagnosis and Treatment (57 papers). Uri Kopylov collaborates with scholars based in Israel, United Kingdom and Canada. Uri Kopylov's co-authors include Shomron Ben‐Horin, Rami Eliakim, Yehuda Chowers, Ernest G. Seidman, Bella Ungar, Miri Yavzori, Orit Picard, Ella Fudim, Eyal Klang and Adi Lahat and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gut.

In The Last Decade

Uri Kopylov

251 papers receiving 8.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

2017 854 citations Rami Eliakim, Uri Kopylov et al. Journal of Crohn s and Colitis profile →

Peers

Countries citing papers authored by Uri Kopylov

Since Specialization

Citations

This map shows the geographic impact of Uri Kopylov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uri Kopylov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uri Kopylov more than expected).

Fields of papers citing papers by Uri Kopylov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uri Kopylov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uri Kopylov. The network helps show where Uri Kopylov may publish in the future.

Co-authorship network of co-authors of Uri Kopylov

This figure shows the co-authorship network connecting the top 25 collaborators of Uri Kopylov. A scholar is included among the top collaborators of Uri Kopylov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uri Kopylov. Uri Kopylov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Elderly‐Onset Inflammatory Bowel Disease Has Distinct Disease Characteristics and Treatment Patterns 2025 ·United European Gastroenterology Journal ·(unknown), Uri Kopylov, (unknown), (unknown), (unknown), (unknown), (unknown), Arad Dotan, Elhanan Borenstein, (unknown), Batia Weiss, Yael Haberman	0
2	P0509 Fecal calprotectin diagnostic level gradient along the small bowel in patients with Crohn’s disease 2025 ·Journal of Crohn s and Colitis ·(unknown), Uri Kopylov, Bella Ungar, (unknown), Eyal Shachar, Tal Engel, Ahmad Albshesh, Doron Yablecovitch, Adi Lahat, Rami Eliakim, Shomron Ben‐Horin	0
3	Computer-Aided Detection Colonoscopy for Surveillance in IBD Patients: Insights from a Single-Center Experience 2025 ·Inflammatory Bowel Diseases ·Adam Goldman, (unknown), Shomron Ben‐Horin, Uri Kopylov, (unknown)	0
4	Capsule Endoscopy in Inflammatory Bowel Disease 2024 ·Gastrointestinal Endoscopy Clinics of North America ·(unknown), Uri Kopylov, (unknown)	3
5	P1067 Pan-enteric mucosal inflammation in CD patients treated with vedolizumab assessed by capsule endoscopy– interim results of a prospective observational study 2024 ·Journal of Crohn s and Colitis ·(unknown), Adi Lahat, Bella Ungar, Hanoch Levy, (unknown), Shomron Ben‐Horin, Rami Eliakim, Uri Kopylov	1
6	Differences in disease characteristics and treatment exposures between paediatric and adult‐onset inflammatory bowel disease using a registry‐based cohort 2024 ·Alimentary Pharmacology & Therapeutics ·(unknown), Uri Kopylov, (unknown), (unknown), (unknown), Shomron Ben‐Horin, Batia Weiss, Yael Haberman	7
7	The Role of Small-Bowel Capsule Endoscopy in the Diagnostic Algorithm of Complicated Perianal Disease 2024 ·Diagnostics ·Irit Avni‐Biron, Ervin Tóth, Jacob E. Ollech, Artúr Németh, (unknown), (unknown), (unknown), Uri Kopylov, Iris Dotan, Henit Yanai	1
8	P801 Umbrella review of effectiveness of digital technologies for the management of Inflammatory Bowel Disease 2024 ·Journal of Crohn s and Colitis ·Marco Gasparetto, Priya Narula, (unknown), James J. Ashton, Jochen Kammermeier, (unknown), Uri Kopylov, Naila Arebi	0
9	P663 Efficacy of jak inhibitors in inflammatory bowel disease patients with extraintestinal manifestations– Retrospective study 2024 ·Journal of Crohn s and Colitis ·(unknown), Yago González Lama, Ioannis E. Κoutroubakis, Ioannis Drygiannakis, Ariella Bar‐Gil Shitrit, (unknown), (unknown), Tamás Molnár, (unknown), Aurélien Amiot, Franck Carbonnel, (unknown), Glen Doherty, Bogdan Mateescu, Shomron Ben‐Horin, Uri Kopylov	0
10	Baseline Data and Measurement Instruments Reported in Observational Studies in Inflammatory Bowel Disease: Results from a Systematic Review 2024 ·Journal of Crohn s and Colitis ·(unknown), (unknown), Valérie Pittet, Peter Bossuyt, Jurij Hanžel, Mark Samaan, Monika Tripathi, Wladyslawa Czuber‐Dochan, Johan Burisch, S. Leone, (unknown), Filip Baert, Uri Kopylov, Susanna Jäghult, Michel Adamina, K Gecse, Naila Arebi	1
11	Precision medicine: Externally validated explainable AI support tool for predicting sustainability of infliximab and vedolizumab in ulcerative colitis 2024 ·Digestive and Liver Disease ·Tom Konikoff, (unknown), Henit Yanai, (unknown), Uri Kopylov, Ahmad Albshesh, Roni Weisshof, (unknown), (unknown), Irit Avni‐Biron, Yifat Snir, (unknown), (unknown), Leor Perl, Iris Dotan, Jacob E. Ollech	0
12	P560 Curcumin-QingDai combination for patients with active ulcerative colitis: A randomized double-blinded placebo-controlled trial 2023 ·Journal of Crohn s and Colitis ·Shomron Ben‐Horin, Nir Salomon, (unknown), N. Viazis, Adi Lahat, Bella Ungar, Rami Eliakim, (unknown), (unknown), Henit Yanai, Idit Dotan, Eran Zittan, (unknown), (unknown), Michal Weitman, G. Mantzaris, Uri Kopylov	2
13	Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn’s Disease: A Multi-Center Retrospective Cohort Study 2023 ·Journal of Clinical Medicine ·Ahmad Albshesh, (unknown), (unknown), Marie Truyens, Stephan R. Vavricka, (unknown), Daniela Pugliese, Edoardo Savarino, Eran Zittan, David Drobne, Xavier Roblin, Ariella Bar‐Gil Shitrit, Alessandro Armuzzi, Triana Lobatón, Nitsan Maharshak, Henit Yanai, Shomron Ben‐Horin, Uri Kopylov	4
14	Development of a Core Outcome Set for Real-world Data in Inflammatory Bowel Disease: A European Crohn’s and Colitis Organisation [ECCO] Position Paper 2022 ·Journal of Crohn s and Colitis ·Jurij Hanžel, Peter Bossuyt, Valérie Pittet, Mark Samaan, Monika Tripathi, Wladyslawa Czuber‐Dochan, Johan Burisch, S. Leone, (unknown), Filip Baert, Uri Kopylov, Susanna Jäghult, Michel Adamina, Naila Arebi, K Gecse	9
15	Incidentally Diagnosed Asymptomatic Crohn’s Disease: A Retrospective Cohort Study of Long-Term Clinical Outcomes 2022 ·Crohn s & Colitis 360 ·(unknown), Bella Ungar, Adi Lahat, Uri Kopylov, Rami Eliakim, Shomron Ben‐Horin	0
16	Patient activation and its association with health indices among patients with inflammatory bowel disease 2022 ·Therapeutic Advances in Gastroenterology ·(unknown), (unknown), Uri Kopylov, (unknown), Racheli Magnezi	4
17	A Narrative Systematic Review and Categorisation of Outcomes in Inflammatory Bowel Disease to Inform a Core Outcome Set for Real-world Evidence 2022 ·Journal of Crohn s and Colitis ·(unknown), (unknown), Peter Bossuyt, Valérie Pittet, Jurij Hanžel, Mark Samaan, Monika Tripathi, Wladyslawa Czuber‐Dochan, Johan Burisch, S. Leone, (unknown), Filip Baert, Uri Kopylov, Susanna Jäghult, Michel Adamina, K Gecse, Naila Arebi	7
18	Ustekinumab during pregnancy in patients with inflammatory bowel disease: a prospective multicentre cohort study 2022 ·Alimentary Pharmacology & Therapeutics ·Irit Avni‐Biron, (unknown), Eran Zittan, (unknown), (unknown), (unknown), (unknown), Uri Kopylov, Yulia Ron, Eran Hadar, (unknown), (unknown), Jacob E. Ollech, Ayelet Arazi, Rivka Farkash, Maor H. Pauker, Henit Yanai, Iris Dotan, Ariella Bar‐Gil Shitrit	24
19	Keeping it simple: mental health assessment in the Gastroenterology Department – using the Hospital Anxiety and Depression Scale (HADS) for IBD patients in Israel 2022 ·Therapeutic Advances in Gastroenterology ·(unknown), (unknown), Michal Taler, (unknown), Doron Gothelf, Uri Kopylov, Shomron Ben‐Horin, (unknown)	7
20	P176. Irritable bowel syndrome frequency in Inflammatory Bowel Disease during both clinical and deep remission and its association with fecal calprotectin 2015 ·Journal of Crohn s and Colitis ·Miriam Fort Gasia, Remo Panaccione, Gilaad G. Kaplan, Sandip Ghosh, Xianyong Gui, Marietta Iacucci, Artúr Németh, Uri Kopylov, Anastasios Koulaouzidis, Gabriele Wurm Johansson, Rami Eliakim, Henrik Thorlacius, Devendra Amre, Ernest G. Seidman, Ervin Tóth, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact